Cargando…

Health Care Utilization and Death in Patients With Heart Failure During the COVID-19 Pandemic

OBJECTIVE: To compare the 1-year health care utilization and mortality in persons living with heart failure (HF) before and during the coronavirus disease 2019 (COVID-19) pandemic. PATIENTS AND METHODS: Residents of a 9-county area in southeastern Minnesota aged 18 years or older with a HF diagnosis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manemann, Sheila M., Weston, Susan A., Jiang, Ruoxiang, Larson, Nicholas B., Roger, Véronique L., Takahashi, Paul Y., Chamberlain, Alanna M., Singh, Mandeep, St. Sauver, Jennifer L., Bielinski, Suzette J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099179/ https://www.ncbi.nlm.nih.gov/pubmed/37229286 http://dx.doi.org/10.1016/j.mayocpiqo.2023.04.004

Ejemplares similares

Rurality, Death, and Healthcare Utilization in Heart Failure in the Community
por: Manemann, Sheila M., et al.
Publicado: (2021)

Premature Myocardial Infarction: A Community Study
por: Dugani, Sagar B., et al.
Publicado: (2021)

Minnesota COVID-19 Lockdowns: The Effect on Acute Myocardial Infarctions and Revascularizations in the Community
por: Lopes, Guilherme S., et al.
Publicado: (2021)

Recent trends in cardiovascular disease deaths: a state specific perspective
por: Manemann, Sheila M., et al.
Publicado: (2021)

Variability in Lipid Levels and Risk for Cardiovascular Disease: An Electronic Health Record–Based Population Cohort Study
por: Manemann, Sheila M., et al.
Publicado: (2023)

Co‐Occurrence of Social Risk Factors and Associated Outcomes in Patients With Heart Failure
por: Savitz, Samuel T., et al.
Publicado: (2023)

Self‐Rated Health Predicts Healthcare Utilization in Heart Failure
por: Chamberlain, Alanna M., et al.
Publicado: (2014)

Perceived Social Isolation and Outcomes in Patients With Heart Failure
por: Manemann, Sheila M., et al.
Publicado: (2018)

Comorbid Depression and Heart Failure: A Community Cohort Study
por: Jani, Bhautesh Dinesh, et al.
Publicado: (2016)

Evaluation of claims‐based computable phenotypes to identify heart failure patients with preserved ejection fraction
por: Cohen, Sarah S., et al.
Publicado: (2020)

Social and behavioural factors associated with frailty trajectories in a population-based cohort of older adults
por: Chamberlain, Alanna M, et al.
Publicado: (2016)

Sex Differences in Associations Between CYP2D6 Phenotypes and Response to Opioid Analgesics
por: Lopes, Guilherme S, et al.
Publicado: (2020)

Contemporary Risk Stratification After Myocardial Infarction in the Community: Performance of Scores and Incremental Value of Soluble Suppression of Tumorigenicity‐2
por: Gerber, Yariv, et al.
Publicado: (2017)

Natural Language Processing and Machine Learning for Identifying Incident Stroke From Electronic Health Records: Algorithm Development and Validation
por: Zhao, Yiqing, et al.
Publicado: (2021)

Longitudinal cohorts for harnessing the electronic health record for disease prediction in a US population
por: Manemann, Sheila M, et al.
Publicado: (2021)

Sex differences in type and occurrence of adverse reactions to opioid analgesics: a retrospective cohort study
por: Lopes, Guilherme S, et al.
Publicado: (2021)

Identification of Incident Atrial Fibrillation From Electronic Medical Records
por: Chamberlain, Alanna M., et al.
Publicado: (2022)

Identification of sex-specific genetic associations in response to opioid analgesics in a White, non-Hispanic cohort from Southeast Minnesota
por: Lopes, Guilherme S., et al.
Publicado: (2022)

Rethinking blood eosinophil counts: Epidemiology, associated chronic diseases, and increased risks of cardiovascular disease
por: Pongdee, Thanai, et al.
Publicado: (2022)

CYP2D6 phenotypes are associated with adverse outcomes related to opioid medications
por: St Sauver, Jennifer L, et al.
Publicado: (2017)

Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events
por: Zhu, Ye, et al.
Publicado: (2021)

Prevalence of co‐occurring serious illness diagnoses and association with health care utilization at the end of life
por: Nothelle, Stephanie, et al.
Publicado: (2022)

Adhesion pathway proteins and risk of atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis
por: Mendez, Israel J., et al.
Publicado: (2021)

Cohort study examining associations between ceramide levels and risk of multimorbidity among persons participating in the Mayo Clinic Biobank
por: St Sauver, Jennifer L, et al.
Publicado: (2023)

Multimorbidity, functional limitations, and outcomes: Interactions in a population-based cohort of older adults
por: Chamberlain, Alanna M, et al.
Publicado: (2019)

Synergistic interactions of obesity with sex, education, and smoking and accumulation of multi-morbidity (MM) across the lifespan
por: St Sauver, Jennifer L, et al.
Publicado: (2023)

Participant perceived understanding and perspectives toward pharmacogenomics: Mayo Clinic Right Drug, Right Dose, Right Time (RIGHT) Protocol
por: Olson, Janet E., et al.
Publicado: (2017)

An assessment of patient perspectives on pharmacogenomics educational materials
por: Asiedu, Gladys B, et al.
Publicado: (2020)

Biomarkers and indoor air quality: A translational research review
por: Senerat, Araliya M., et al.
Publicado: (2020)

Multimorbidity, ageing and mortality: normative data and cohort study in an American population
por: Rocca, Walter A, et al.
Publicado: (2021)

Convergence of four measures of multi-morbidity
por: Grossardt, Brandon R., et al.
Publicado: (2023)

No Decline in the Risk of Stroke Following Incident Atrial Fibrillation Since 2000 in the Community: A Concerning Trend
por: Chamberlain, Alanna M., et al.
Publicado: (2016)

Pathway to Ascertain the Role of Pharmacogenomics in Healthcare Utilization Outcomes [Response to Letter]
por: Takahashi, Paul Y, et al.
Publicado: (2021)

Coronary Disease Surveillance in the Community: Angiography and Revascularization
por: Gerber, Yariv, et al.
Publicado: (2020)

Comparing outcomes and costs among warfarin-sensitive patients versus warfarin-insensitive patients using The Right Drug, Right Dose, Right Time: Using genomic data to individualize treatment (RIGHT) 10K warfarin cohort
por: Swanson, Kristi M., et al.
Publicado: (2020)

Impact of Diverse Data Sources on Computational Phenotyping
por: Wang, Liwei, et al.
Publicado: (2020)

Multi-morbidity and patient-reported functional limitations: a population-based cohort study
por: Chamberlain, Alanna M, et al.
Publicado: (2022)

Systematic review of the evidence on the cost-effectiveness of pharmacogenomics-guided treatment for cardiovascular diseases
por: Zhu, Ye, et al.
Publicado: (2019)

White blood cells and chronic rhinosinusitis: a Mendelian randomization study
por: Pongdee, Thanai, et al.
Publicado: (2022)

Inflammatory biomarkers, multi-morbidity, and biologic aging
por: St. Sauver, Jennifer, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lhlop91ktpdee9lfdkgfoj12jp